Research Proposal Example for Nursing Students

INSTITUTIONAL CLINICAL RESEARCH ENGAGEMENT AND PROPOSAL SERVICES AGREEMENT

Document ID: CRA-NUR-2024-V1.0
Effective Date: [Effective Date]
Version: 1.0.0
Governing Jurisdiction: [State / Country Jurisdiction]

---

1. STATUTORY & LEGAL COMPLIANCE NOTICE

This institutional-grade Clinical Research Engagement and Proposal Services Agreement ("Agreement") is drafted in accordance with professional legal, academic, and clinical research standards. The research proposal example annexed hereto or developed hereunder is intended solely for educational, institutional, and evidence-based nursing practice development.

Clinical & Regulatory Disclaimer: The parties acknowledge that any clinical research, evidence-based practice (EBP) project, or quality improvement (QI) initiative described or formulated herein must strictly adhere to institutional review board (IRB) regulations, the Health Insurance Portability and Accountability Act (HIPAA), the Family Educational Rights and Privacy Act (FERPA) where applicable, and all local, state, and federal statutory mandates governing human subjects research. Jurisdictional enforceability of clinical protocols, intellectual property assignments, and data protection provisions shall be interpreted in accordance with the laws of [State / Country Jurisdiction].

---

2. PARTIES & RECITALS

THIS CLINICAL RESEARCH ENGAGEMENT AND PROPOSAL SERVICES AGREEMENT (the "Agreement") is entered into as of [Effective Date] (the "Effective Date"), by and between:

Provider / Institution: [Company Full Legal Name], a [State of Incorporation/Organization] [Corporate Entity Type, e.g., corporation/limited liability company], having its principal place of business located at [Principal Address] (hereinafter referred to as the "Provider"), and

Client / Researcher: [Client Full Legal Name], an individual / [Corporate Entity Type] having a principal address or registered office located at [Principal Address] (hereinafter referred to as the "Client").

RECITALS:

WHEREAS, the Provider possesses specialized expertise in clinical research methodology, nursing science, academic proposal drafting, evidence-based practice framework design, and institutional review board (IRB) protocol optimization;

WHEREAS, the Client desires to retain the Provider to design, draft, structure, and refine an exhaustive, institutional-grade nursing research proposal (the "Services"), conforming to rigorous academic and clinical standards; and

WHEREAS, the parties intend to define the terms and conditions governing the provision of such Services, the compensation therefor, the allocation of intellectual property rights, and the protection of confidential information.

NOW, THEREFORE, in consideration of the mutual covenants, promises, and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

---

3. EXHAUSTIVE OPERATIVE CLAUSES & LEGAL TERMS

Section 1: Scope of Services & Engagement

1.1 Engagement: The Client hereby engages the Provider, and the Provider accepts such engagement, to perform the professional clinical research proposal development services outlined in this Agreement and any mutually executed Statement of Work (SOW). 1.2 Scope of Work: The Services shall specifically include, but are not limited to: (a) formulating the clinical research problem statement and specific aims; (b) conducting a rigorous literature synthesis utilizing evidence-based nursing frameworks; (c) designing the methodological approach (quantitative, qualitative, or mixed methods); (d) drafting data collection instruments, recruitment strategies, and safety monitoring plans; and (e) preparing regulatory documentation templates suitable for submission to an Institutional Review Board (IRB) or academic review committee. 1.3 Standard of Performance: The Provider covenants that all Services shall be executed by qualified personnel holding appropriate clinical, academic, and methodological credentials, and in strict accordance with prevailing professional standards in the nursing research community.

Section 2: Compensation & Payment Terms

2.1 Total Fee: In consideration for the full and faithful performance of the Services, the Client shall pay to the Provider the total sum of [Amount in USD] USD (the "Contract Price"), payable in accordance with the milestone schedule set forth in Exhibit A or as otherwise agreed in writing. 2.2 Invoicing: The Provider shall issue formal invoices to the Client upon the completion of designated project milestones or upon the occurrence of billing dates specified herein. Each invoice shall itemize the Services rendered and applicable expenses. 2.3 Payment Due Date: All invoices are due and payable within thirty (30) calendar days from the date of receipt of the invoice by the Client (the "Due Date"). 2.4 Late Interest: Any undisputed amounts not paid by the Client when due shall accrue interest at the lesser of one and one-half percent (1.5%) per month or the maximum rate permitted by applicable law, calculated from the Due Date until the date of actual payment in full. 2.5 Suspension of Services: If any invoice remains unpaid for more than fifteen (15) days past the Due Date, the Provider reserves the right, upon written notice to the Client, to suspend the performance of any further Services until all delinquent accounts, including accrued interest, are paid in full.

Section 3: Term & Termination

3.1 Term: This Agreement shall commence on the Effective Date and shall continue until the complete delivery and acceptance of the final research proposal, or until terminated earlier in accordance with the provisions of this Section 3 (the "Term"). 3.2 Termination for Convenience: The Client may terminate this Agreement, or any active Statement of Work, at any time for any reason, or no reason, by providing thirty (30) days prior written notice to the Provider. Upon such termination, the Client shall pay the Provider for all Services satisfactorily rendered up to the effective date of termination, plus any non-cancellable commitments reasonably incurred by the Provider. 3.3 Termination for Cause: Either party may terminate this Agreement immediately upon written notice if the other party materially breaches any provision of this Agreement and fails to cure such material breach within fifteen (15) calendar days after receipt of written notice detailing the breach. 3.4 Effect of Termination: Upon termination of this Agreement for any reason, the Provider shall promptly deliver to the Client all work product, drafts, data, and deliverables completed up to the date of termination, subject to receipt of full payment for rendered services, and each party shall return or destroy all Confidential Information of the other party in accordance with Section 5.

Section 4: Intellectual Property Ownership & Work Made for Hire

4.1 Work Made for Hire: The parties agree that all deliverables, research proposals, drafts, analytical models, data sets, and associated documentation created by the Provider specifically for the Client pursuant to this Agreement (collectively, the "Work Product") shall, to the maximum extent permitted by law, be deemed a "work made for hire" for the Client. 4.2 Assignment of Rights: To the extent that any Work Product does not qualify as a work made for hire under applicable law, the Provider hereby irrevocably assigns, transfers, and conveys to the Client all right, title, and interest worldwide in and to such Work Product, including all copyright, patent, trade secret, and other intellectual property rights therein. 4.3 Provider Pre-Existing IP: Notwithstanding the foregoing, the Provider retains sole and exclusive ownership of all pre-existing methodologies, templates, research frameworks, algorithms, know-how, and proprietary tools owned or developed by the Provider prior to the Effective Date or developed independently of this Agreement ("Provider Background IP"). The Provider hereby grants to the Client a perpetual, non-exclusive, royalty-free, worldwide license to use, execute, and incorporate Provider Background IP solely as integrated into the final delivered Work Product.

Section 5: Mutual Confidentiality & Non-Disclosure

5.1 Definition of Confidential Information: "Confidential Information" shall include all non-public information, data, clinical protocols, patient data (de-identified or otherwise), proprietary methodologies, trade secrets, financial details, and business plans disclosed by one party (the "Disclosing Party") to the other party (the "Receiving Party"), whether orally, visually, or in writing, that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure. 5.2 Obligations of Confidentiality: The Receiving Party agrees to: (a) maintain the strict confidentiality of all Disclosing Party Confidential Information using at least the same degree of care it uses for its own confidential information, but in no event less than a reasonable degree of care; (b) not disclose such Confidential Information to any third party, except to its directors, officers, employees, legal counsel, and clinical advisors who have a strict need to know and who are bound by confidentiality obligations at least as restrictive as those contained herein; and (c) not use such Confidential Information for any purpose other than the performance of its obligations or the exercise of its rights under this Agreement. 5.3 Exclusions: Confidential Information shall not include information that: (a) is or becomes generally known to the public through no breach of this Agreement by the Receiving Party; (b) was already known to the Receiving Party prior to disclosure without an obligation of confidentiality; (c) is independently developed by the Receiving Party without reference to or reliance upon the Disclosing Party's Confidential Information; or (d) is required to be disclosed by law, regulation, or court order, provided that the Receiving Party gives prompt written notice to the Disclosing Party to enable the Disclosing Party to seek a protective order.

Section 6: Representations & Warranties

6.1 Mutual Representations: Each party represents and warrants to the other that: (a) it has the full corporate power and authority to enter into this Agreement and to perform its obligations hereunder; (b) the execution and delivery of this Agreement have been duly authorized by all necessary corporate or organizational action; and (c) this Agreement constitutes a legal, valid, and binding obligation enforceable against such party in accordance with its terms. 6.2 Provider Warranties: The Provider warrants that: (a) the Services shall be performed in a professional, workmanlike manner consistent with the highest standards of the clinical research and nursing academic communities; and (b) the final Work Product shall be original and shall not knowingly infringe, misappropriate, or violate any copyright, trademark, patent, trade secret, or other intellectual property right of any third party. 6.3 Disclaimer of Implied Warranties: EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 6, NEITHER PARTY MAKES ANY OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR ACADEMIC SUCCESS/IRB APPROVAL OF THE RESEARCH PROPOSAL.

Section 7: Limitation of Liability & Indemnification

7.1 Limitation of Liability: TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, PUNITIVE, OR EXEMPLARY DAMAGES, INCLUDING LOSS OF PROFITS, LOSS OF REVENUE, LOSS OF DATA, OR BUSINESS INTERRUPTION, ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, REGARDLESS OF THE THEORY OF LIABILITY (CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY, OR OTHERWISE), EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 7.2 Aggregate Liability Cap: The total aggregate liability of either party arising out of or relating to this Agreement, under any and all legal theories, shall be strictly limited to the total Contract Price actually paid by the Client to the Provider under this Agreement. 7.3 Indemnification: Each party (the "Indemnifying Party") agrees to defend, indemnify, and hold harmless the other party, its officers, directors, employees, agents, and clinical affiliates (the "Indemnified Party") from and against any and all third-party claims, liabilities, losses, damages, judgments, costs, and expenses (including reasonable attorneys' fees) arising out of or resulting from: (a) the gross negligence or willful misconduct of the Indemnifying Party; or (b) any material breach of this Agreement by the Indemnifying Party.

Section 8: Dispute Resolution & Arbitration

8.1 Negotiation: In the event of any dispute, controversy, or claim arising out of or relating to this Agreement, the parties shall first attempt in good faith to resolve the matter through direct business negotiations between senior executives or designated representatives of each party for a period of thirty (30) days. 8.2 Binding Arbitration: If the dispute is not resolved through negotiation within thirty (30) days, the matter shall be submitted to final and binding arbitration administered by the American Arbitration Association (AAA) in accordance with its Commercial Arbitration Rules. The place of arbitration shall be [City, State]. The arbitration shall be conducted by a single neutral arbitrator appointed in accordance with said rules. The award rendered by the arbitrator shall be final and binding, and judgment upon the award may be entered in any court having jurisdiction thereof.

Section 9: Governing Law & Jurisdiction

9.1 Governing Law: This Agreement, and all claims or causes of action (whether in contract, tort, or statute) that may be based upon, arise out of, or relate to this Agreement, shall be governed by, enforced under, and construed in accordance with the internal laws of [State / Country Jurisdiction], without regard to its conflict of laws principles. 9.2 Jurisdiction: Subject to Section 8, each party irrevocably and unconditionally submits to the exclusive jurisdiction of the state and federal courts located within [County, State / Country Jurisdiction] for any legal action, suit, or proceeding arising out of or relating to this Agreement.

Section 10: Miscellaneous

10.1 Severability: If any provision of this Agreement is held to be invalid, illegal, or unenforceable by a court or arbitrator of competent jurisdiction, such provision shall be modified to the minimum extent necessary to make it valid and enforceable, and the remaining provisions of this Agreement shall remain in full force and effect. 10.2 Counterparts: This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Electronic signatures, facsimile signatures, and PDF signatures shall be deemed original signatures for all purposes. 10.3 Entire Agreement: This Agreement, together with any attached exhibits or SOWs, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous understandings, agreements, representations, and warranties, both written and oral. 10.4 Amendments & Waivers: No amendment, modification, or waiver of any provision of this Agreement shall be effective unless set forth in a written instrument signed by authorized representatives of both parties. No failure or delay by either party in exercising any right, power, or remedy under this Agreement shall operate as a waiver thereof.

---

4. EXECUTION & FORMAL SIGNATURE BLOCKS

IN WITNESS WHEREOF, the parties hereto have caused this Institutional Clinical Research Engagement and Proposal Services Agreement to be executed by their respective duly authorized officers as of the Effective Date first written above.

FOR [COMPANY FULL LEGAL NAME] (PROVIDER):

Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Company Full Legal Name]
Date: [Date]

FOR [CLIENT FULL LEGAL NAME] (CLIENT):

Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Client Full Legal Name] (if applicable)
Date: [Date]

---

5. STEP-BY-STEP EXECUTION & FILING GUIDE

To ensure full legal enforceability, institutional compliance, and operational integrity, follow these precise steps when finalizing and executing this document:

1. Document Customization: Open this template in Microsoft Word, Google Docs, or a comparable secure document editor. Locate all bracketed text strings (e.g., [Company Full Legal Name], [Client Full Legal Name], [Principal Address], [Effective Date], [Amount in USD], and [State / Country Jurisdiction]) and replace them with accurate, verified legal data.
2. Signatory Verification: Verify that the individuals signing on behalf of both the Provider and the Client possess explicit corporate or institutional authority to bind their respective organizations to financial and operational commitments.
3. Execution via Digital Signature Platform: Upload the finalized, un-bracketed document to an institutional-grade digital signature platform compliant with ESIGN and UETA standards (such as DocuSign, Adobe Sign, or HelloSign). Route the agreement to the designated signatories in sequence.
4. Archival and Record Retention: Upon full execution by both parties, generate a secure, cryptographic Certificate of Completion. Store the fully executed PDF agreement and audit trail within the organization's centralized contract management repository (CLM) or secure encrypted cloud storage for a minimum retention period of seven (7) years, or as mandated by institutional compliance policies.